Introduction: The research focuses on the clinical study of cerebral angioarchitectonics and microcirculation disorders in the development of Alzheimer's disease (AD) in comparison with other neurodegenerative and ischemic lesions. Materials and methods: 1117 patients with different types and stages of neurodegenerative and ischemic lesions were examined, 93 of whom (8.33%) had different stages of AD-Test Group; 1024 (91.67%) had cerebral atherosclerosis, Binswanger disease (BD), vascular Parkinsonism (VP)-Control Group. The examination included definition of CDR, MMSE, cerebral CT, MRI, cerebral sciagraphy (SG), rheoencephalography (REG), morphometric detection of AD stages with TDR, and cerebral multi-gated angiography (MUGA). Results: In all patients with AD, regardless of the disease stage, specific сerebral small vessel disease (CSVD), manifested by dyscirculatory angiopathy of Alzheimer's type (DAAT), was detected in the temporal and fronto-parietal areas. Conclusions: DAAT is an AD-specific lesion of cerebral microvessels that changes hemodynamics, causes cerebral hypoxia, and contributes to impaired amyloid beta metabolism. The combination of deposition of amyloid beta in the cerebral tissue and vascular wall, as well as specific disorders of microcirculation, cause neurodegeneration and AD development. Patients with other neurodegenerative and ischemic lesions had no DAAT manifestations.
Introduction
Cerebral ischemic and neurodegenerative diseases are increasingly observed among the population of different countries [1] . The most common of them are atherosclero sclerosis of the brain, Alzheimer's disease (AD), Binswanger's disease (BD), and Parkinsonism. All these diseases lead to the progression of dementia and cognitive disorders and are also accompanied by the development of cerebral small vessel disease (CSVD) [2] [3] [4] . This condition is caused by the peculiarity of the microcirculation in the brain, since there are about 3 -4 thousand capillaries in one cubic centimeter of the cerebral tissue. With such a high demand for blood supply, disorders in hemoperfusion and hemodynamics cause or contribute to the development of neurodegenerative processes [5] .
In the early stages, clinical pictures of these diseases have much in common. AD is one the leading neurodegenerative diseases nowadays. Currently, there are over 36 million people suffering from AD [1] [4] . In the USA, this disease affects more than 5 million people, while 5% of them acquire AD at a fairly young age [1] .
AD begins to develop in secret, years or even decades before the primary manifestations of the disease [6] . The preclinical stage of AD, in which the patient does not make any classical complaints, is difficult to detect [1] . Since this disease is often hereditary, it is necessary to examine AD patients' relatives and descendants for the detection of its preclinical stage [1] . It shows that the true number of patients suffering from AD can be much greater [1] [6] .
AD is accompanied by the development of involutive changes in the hippocampus and temporal cerebral lobes, but the etiology and pathogenesis of this disease have not been fully studied [7] . In recent years, the use of CT, MRI, PET, the introduction of biomarkers, and research on biological models have made it possible to achieve serious results in the study of structural and morphological changes taking place in the brain tissue during this disease, as well as to achieve success in understanding the distribution of amyloid beta and tau [6] [8]- [14] .
However, the dependence of cerebral involutive changes and the disorders in cerebral angioarchitectonics and microcirculation is not completely clear [15] [16] [17] [18] [19] .
Cerebral small vessel disease (CSVD) and cerebral hypoperfusion are important in the development of AD [3] [17] [19] - [24] . These processes are specific and connected with disorders in capillary blood supply [17] [19] [20] [21] . Patients undergo a change in the distal arterial and capillary bed, which leads to damaging the neurovascular unit (NVU) in the form of reduction in the number of microvessels and damaging tissue elements [17] [18] [22] .
These changes lead to neuronal degeneration, a decrease in the clearance and an increase in the accumulation of amyloid causing further neurovascular dysfunction and neurodegeneration [18] [21] [25] [26] [27] . Beta amyloid deposits in the cerebral tissue and especially in the vascular wall reduce the elasticity of microvessels and cause the narrowing of their lumen reducing in a higher degree the cerebral blood flow, which in its turn causes more active amyloid deposition and accelerates AD development [28] .
There is no complete clinical picture of all CSVD components involved in the 
Materials and Methods

Patient Selection
All the research described in this paper was accomplished with the approbation of the Ethics Committee and with the agreement of the examined patients and their relatives.
We selected 1117 patients who were 34 -81 years old, mean age being 75.5 of whom men comprised 792 (70.90%) cases and women 325 (29.10%) cases. Those patients had primary signs of cerebral neurodegeneration or suffered from marked neurodegenerative lesions of the brain.
Patient Examination
Examination plan:  dementia severity was clinically assessed in accordance with the Clinical Dementia Rating scale (CDR) [30] ;  cognitive functions were evaluated with the help of Mini-Mental State Examination (MMSE) [31] ;  coagulogical, biochemical and general clinical indicators were measured by laboratory tests;  brain scintigraphy (SG), with ТС 99М pertechnetate 555, was executed using a gammacamera (Ohio Nuclear Company, USA) and following the classical method in dynamic and static modes;  rheoencephalography (REG) was accomplished in standard automatic modes determining disorders in pulse blood volume in the cerebral hemispheres using "Reospektr-8" (Neurosoft Company, Russia);  CТ and MRI of the brain were conducted by means of "Somatom" (Siemens), "Hi Speed" (GE), "Tomoscan" (Philips), "Apetro Eterna" (Hitachi). The ATAA (Advance Tomo Area Analysis) [ [32] . The method allows the determination of dementia stages during AD taking into account the severity of atrophic changes of the temporal lobes shown by CT and MRI.
The essence of the method is the following. During CT or MRI, using the Advance Tomo Area Analysis computer program (ATAA) [24] , the area of the middle cranial fossa is measured successively on each scan. The automatically obtained data are recalculated by the thickness of the scan, then the scans are summed and the volume of the middle cranial fossa is determined corresponding to the normal volume of the cerebral tissue of the temporal regions [29] . Simultaneously, the percentage of tissue loss in the cerebral temporal lobes is calculated in each case [17] . Next, the obtained reduced volumes of temporal lobes are compared with the clinical picture of dementia on the CDR scale, which results in an objective, morphometrically validated assessment of the stage of dementia in AD [32] ;  cerebral multi-gated angiography (MUGA) was executed using "Advantx" (GE) by transfemoral access following the classical method of introducing Omnipack 350, 10 -12 ml intracarotidally and 7 -8 ml intravertebrally. The procedure was conducted in front and side projections, at the registration speed of 25 shots per second and in the mode of constant subtraction [17] [19] .
Capillary blood flow was measured by Angio Vision computer program [23] which allows to define the changes in the density and the number of black pixels in the corresponding area of the cerebral angiographic image as radiopaque substance passes through arterioles and capillaries [17] [19] . Recently, a similar program with the addition of 2D effects has been proposed by Philips [33] .
Test Group
93 (8.33%) patients of 34 -79 years old, mean age 67: 32 men (34.40%) and 61 (65.59%) women. They had different AD stages. The number of patients in the control group is determined by the need to compare vascular, microcirculatory and atrophic changes in the brain in the above-mentioned nosology to specific changes found among test group patients.
Control Group
Results
Test Group
In accordance with CT and MRI data, we identified specific, morphometrically validated, atrophic changes in the hippocampus and temporal lobes corresponding to different AD stages with a certain level of dementia. Thanks to these data and the developed classification called Tomography Dementia Rating scale (TDR) [32] , the patients were divided:  at the time of this research, 10 (10.75%) patients had preclinical AD stage (Table 1) ;  at the time of this research, 17 (18.28%) patients had late AD stage TDR-3 due to severe dementia. Cognitive functions were reduced to 7 -11 MMSE points, dementia was at the level of CDR-3, involutive changes in the brain were manifested by the atrophy of the temporal lobes with a 33% -62% decrease in the tissue mass. The anamnesis of the disease was 7 -11 years (Figure 1(D) ), ( Table 1) .
The general character of the cerebral involutive changes is presented in Table   1 . To define the differences of the symptoms under study, we conducted an analysis of contingency tables with Chi-square criterion. All the figures except for "Sylvian fissures widening signs" revealed significant differences (p < 0.01). The statistical analysis was accomplished with the help of Statsoft Statistica 10 program.
According to laboratory tests:  35 (37.63%) patients had increased blood lipids level. We named the combination of these changes in cerebral microcirculation and Angioarchitectonics, which are specific for AD and which lead to dysregulation of blood flow, "dyscirculatory angiopathy of Alzheimer's type" (DAAT) [17] [19] [29] . To define the differences in the symptoms under study, we conducted an analysis of contingency tables with Chi-square criterion. All the figures revealed significant differences (p < 0.01). The statistical analysis was accomplished with the help of Statsoft Statistica 10 program.
Control Group
According to CT and MRI:  No isolated atrophic changes of the hippocampus and temporal lobes of the brain specific for AD were detected in any case (Table 1) ;  There were general cerebral involutive and neurodegenerative changes of different localization and severity in all 1024 cases (100%) ( Table 1 Figure   3 (D1));  subcortical, disseminated, early discharge of arterial blood into the venous bed at the level of the white matter of the brain-392 (38.28%) patients;  no cases of AD-specific, abnormally widened, laterally located venous trunks at the level of fronto-parietal areas;  no cases of AD-specific stagnation of venous blood at the border of the frontal and parietal area;  development of increased looping of distal intracranial arterial branches-69 (6.74%) patients (Figure 3(B2) ).
Thus, the obtained data suggest that the abovementioned changes identified in Control Group patients are completely different from the changes detected in Test Group patients. 
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Discussion
Research aimed at studying vascular and microcirculatory disorders in AD has been basically conducted using post-mortem autopsies [20] All 93 (100%) Test Group patients showed a decrease in the number of microvessels and depletion of the capillary bed, which leads to the development of hypovascular zones in the temporal and fronto-parietal areas.
The blood flowing through larger arterial branches cannot get through reduced arterioles and capillaries, which leads to arteriovenous shunts in the corresponding cerebral regions making hypoxia worse.
Arteriovenous shunts are a natural defensive reaction of the organism against the failure of distal blood to flow smoothly through the capillary bed [5] [17] [19] . Due to these shunts, arterial blood is dumped into the venous bed. [36] , the reduction of the distal arterial influx and the development of cerebral hypoperfusion and hypoxia [35] [37]- [43] . As it has been noted in many works, these microvascular disorders cause neurovascular dysfunction [22] Involutive and hypotrophic changes in the brain in Control Group patients develop according to the ischemic, often disseminated type; they differ from the involutive changes occurring in Test Group patients with AD and are usually associated with the zones of cerebral ischemia.
Conclusions
Cerebral vascular and microcirculatory disorders in AD represent dyscirculatory World Journal of Neuroscience angiopathy of Alzheimer's type (DAAT). These specific changes lead to the development of hypoxia, cause intercellular disorders, contribute to disorders in the metabolism of amyloid beta and to involutive changes in the temporal regions. The combination of these changes is a distinctive feature of AD in comparison with other ischemic and neurodegenerative diseases.
Vascular and microcirculatory changes in Control Group patients are of different genesis and do not lead to the development of DAAT. These changes are different, and often atherosclerotic, and lead to the development of other cerebral ischemic and neurodegenerative lesions.
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